Sano Genetics

The company combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrolment and simplifying operations for precision medicine teams driving breakthroughs for patients.

In 2023 alone, Sano Genetics experienced 5x ARR growth year-on-year, doubled its headcount to 62 and expanded into the large pharmaceutical market, working with four of the top 20 pharma companies.

In January 2024, the company raised $11.4m in new funding led by Plural with participation from existing investors including MMC Ventures, Episode 1 and Seedcamp.